Patient-Centered Innovations, Education and Technology for Cancer Care and Cancer Research
JMIR Cancer (JC) is a new peer-reviewed journal with a focus on education, innovation and technology in cancer care and cancer research, as well as in participatory and patient-centred approaches. A sister journal of the Journal of Medical Internet Research (JMIR), a leading eHealth journal (Impact Factor 2015: 4.532), the scope of JC is broader and includes non-Internet approaches to improve cancer care and cancer research.
We invite submission of original research, viewpoints, reviews, tutorials, case studies, and non-conventional articles (e.g. open patient education material and software resources that are not yet evaluated but free for others to use/implement).
In our "Patients' Corner", we invite patients and survivors to submit short essays and viewpoints on all aspects of cancer, but in particular suggestions on how to improve the health care system, and suggestions for new technologies, applications and approaches (no article processing fees).
Articles published in JC will be submitted to PubMed and Pubmed Central. JC is open access and all articles are published under a Creative Commons Attribution license.
Sep 19, 2016
Sep 14, 2016
Aug 30, 2016
Aug 25, 2016
Aug 19, 2016
Jul 19, 2016
Jun 7, 2016
May 31, 2016
May 24, 2016
May 10, 2016
May 9, 2016
May 4, 2016
Citing this Article
Right click to copy or hit: ctrl+c (cmd+c on mac)
Latest Submissions Open for Peer-Review:View All Open Peer Review Articles
Clinical Trial Electronic Portals for Expedited Safety Reporting: Current Issues and Desired Features
Date Submitted: Sep 27, 2016
Open Peer Review Period: Sep 28, 2016 - Nov 23, 2016
Background: Use of electronic clinical trial portals has increased in recent years to assist with sponsor-investigator communication, safety reporting, and clinical trial management. Electronic porta...
Background: Use of electronic clinical trial portals has increased in recent years to assist with sponsor-investigator communication, safety reporting, and clinical trial management. Electronic portals can help reduce time and costs associated with processing paperwork and add security measures; however, there is a lack of information on clinical trial investigative staff’s perceived challenges and benefits of using portals. Objective: The Clinical Trials Transformation Initiative (CTTI) sought to (1) identify challenges to investigator receipt and management of investigational new drug (IND) safety reports at oncologic investigative sites and coordinating centers and (2) facilitate adoption of best practices for communicating and managing IND safety reports using electronic portals consistent with the United States (US) Food and Drug Administration’s (FDA) guidance, the IND safety rule, and CTTI recommendations. Methods: CTTI, a public-private partnership to improve the conduct of clinical trials, distributed surveys and conducted interviews in an opinion-gathering effort to record investigators’ and research staff views on electronic portals in the context of the new safety reporting requirements described in the FDA’s final rule (Code of Federal Regulation 21.312). Results: The top challenge investigators/staff identified in using individual sponsor portals was remembering several, complex, individual passwords to access each site. Also, certain time-consuming tasks (e.g., downloading reports) are due to slow sites or difficulties associated with particular operating systems or software. To improve user experiences, respondents suggested that portals function independently of browsers and operating systems, have intuitive interfaces with easy navigation, and incorporate additional features that would allow users to filter, search, and batch safety reports. Conclusions: Results indicate that an ideal system for sharing expedited IND safety information is through a central portal used by all sponsors. Until this is feasible, electronic reporting portals should at least have consistent functionality. CTTI has issued recommendations to improve the quality and use of electronic portals.